COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

This study will be a double-blind, randomized, placebo controlled, parallel-group study to evaluate the effect of Aclidinium bromide on the cardiovascular safety and COPD exacerbations in patients with moderate to very severe COPD, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria (GOLD, 2011). The objectives ...

If you or a loved one has Chronic Obstructive Pulmonary Disease (COPD), you may be interested in this clinical research study. This study is testing the benefits of an investigational drug in reducing lung and heart complications in people with COPD.

The purpose of this study is to evaluate the safety, tolerability and efficacy of inhaled aclidinium bromide at two dose levels in patients with moderate to severe, stable chronic obstructive pulmonary disease. The study will be 56 weeks in duration; a 2-week rin-in period, a 52-week treatment period and a ...

Are you experiencing Chronic Obstructive Pulmonary Disease (COPD)? Is your COPD moderate to severe you may be interested in learning more about a clinical research study that we are conducting.

Are you a current or former smoker? Do you have trouble breathing or a persistent cough? If so, you may have a disease called Chronic Obstructive Pulmonary Disease or COPD. We are looking for people who are between 40 and 80 years old with COPD to participate in a clinical ...

A 24 week randomized, double-blind, chronic dosing, placebo controlled study group to assess the effect and safety of PT003, PT005, and PT001 in subjects with moderate to severe COPD.

A 52 week double-blind, placedbo controlled study to evaluate the effect of roflumilast on the exacerbation rate in patients with COPD.

Montana Medical Research is now enrolling a Clinical Research Trial for Chronic Obstructive Pulmonary Disease.

Patient Inclusion Criteria: Must be between 40-80 years old and able to give consent Must have current diagnosis of moderate to severe COPD Current or prior cigarette smoking history of ≥10 pack-years Subjects must have a qualified cardiovascular indication Subjects must meet Spirometry measurements at screening Compensation will be made ...

If you or a loved one has Chronic Obstructive Pulmonary Disease (COPD), you may be interested in this clinical research study. This study is testing the benefits of an investigational drug in reducing lung and heart complications in people with COPD. Individuals may qualify for this study if they: Have ...